|Bid||0.8200 x N/A|
|Ask||0.9000 x N/A|
|Day's Range||0.8100 - 0.8300|
|52 Week Range||0.6000 - 1.2000|
|Beta (5Y Monthly)||1.25|
|PE Ratio (TTM)||5.79|
|Earnings Date||Jan 22, 2024 - Jan 26, 2024|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Low-cost index funds make it easy to achieve average market returns. But if you invest in individual stocks, some are...
Cannara Biotech Inc. ("Cannara" or the "Company") (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB), a vertically integrated producer of premium-grade cannabis and derivative product offerings at affordable prices with two mega facilities based in Quebec spanning over 1,650,000 sq. ft., today announced its fiscal third quarter 2023 financial and operating results for the three- and nine-month periods ended May 31, 2023.
Montreal, Quebec--(Newsfile Corp. - May 23, 2023) - Cannara Biotech Inc (TSXV: LOVE) announced today that it will be presenting at the 13th Annual LD Micro Invitational at the Luxe Sunset Boulevard Hotel, California on June 6th-8th, 2023. The event is expected to feature 150+ companies, presenting in half-hour increments, as well as private 1:1 meetings. Cannara Biotech Inc is scheduled to present on June 7th at 3:00 PM PT. Nicholas ...